Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 135

1.

Prevalence and determinants of co-morbidities in patients with obstructive apnea and chronic obstructive pulmonary disease.

Spicuzza L, Campisi R, Crimi C, Frasca E, Crimi N.

Eur J Intern Med. 2019 Sep 5. pii: S0953-6205(19)30307-3. doi: 10.1016/j.ejim.2019.08.020. [Epub ahead of print] No abstract available.

PMID:
31494020
2.

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry.

Canonica GW, Colombo GL, Bruno GM, Di Matteo S, Martinotti C, Blasi F, Bucca C, Crimi N, Paggiaro P, Pelaia G, Passalaqua G, Senna G, Heffler E; SANI Network.

World Allergy Organ J. 2019 Jan 26;12(1):100007. doi: 10.1016/j.waojou.2018.12.001. eCollection 2019.

3.

Vitamin D and disease severity in bronchiectasis.

Ferri S, Crimi C, Heffler E, Campisi R, Noto A, Crimi N.

Respir Med. 2019 Mar;148:1-5. doi: 10.1016/j.rmed.2019.01.009. Epub 2019 Jan 24.

PMID:
30827468
4.

Early management of COPD: where are we now and where do we go from here? A Delphi consensus project.

Di Marco F, Balbo P, de Blasio F, Cardaci V, Crimi N, Girbino G, Pelaia G, Pirina P, Roversi P, Santus P, Scichilone N, Vatrella A, Pasqualetti P, Carone M.

Int J Chron Obstruct Pulmon Dis. 2019 Feb 4;14:353-360. doi: 10.2147/COPD.S176662. eCollection 2019. Review.

5.

Bronchiectasis and asthma: a dangerous liaison?

Crimi C, Ferri S, Crimi N.

Curr Opin Allergy Clin Immunol. 2019 Feb;19(1):46-52. doi: 10.1097/ACI.0000000000000492. Review.

PMID:
30516546
6.

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.

Marzano AV, Genovese G, Casazza G, Fierro MT, Dapavo P, Crimi N, Ferrucci S, Pepe P, Liberati S, Pigatto PD, Offidani A, Martina E, Girolomoni G, Rovaris M, Foti C, Stingeni L, Cristaudo A, Canonica GW, Nettis E, Asero R.

J Eur Acad Dermatol Venereol. 2019 May;33(5):918-924. doi: 10.1111/jdv.15350. Epub 2018 Dec 7.

PMID:
30451325
7.

Mediterranean Diet and Particulate Matter Exposure Are Associated With LINE-1 Methylation: Results From a Cross-Sectional Study in Women.

Barchitta M, Maugeri A, Quattrocchi A, Barone G, Mazzoleni P, Catalfo A, De Guidi G, Iemmolo MG, Crimi N, Agodi A.

Front Genet. 2018 Oct 30;9:514. doi: 10.3389/fgene.2018.00514. eCollection 2018.

8.

The Severe Asthma Network in Italy: Findings and Perspectives.

Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G, Senna G, Canonica GW; SANI Network.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1462-1468. doi: 10.1016/j.jaip.2018.10.016. Epub 2018 Oct 25.

PMID:
30368004
9.

Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients.

Crimi C, Heffler E, Augelletti T, Campisi R, Noto A, Vancheri C, Crimi N.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 8;13:3131-3139. doi: 10.2147/COPD.S171134. eCollection 2018.

10.

Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.

Heffler E, Crimi C, Mancuso S, Campisi R, Puggioni F, Brussino L, Crimi N.

Respir Med. 2018 Sep;142:48-52. doi: 10.1016/j.rmed.2018.07.015. Epub 2018 Jul 24.

PMID:
30170801
11.

The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition.

Heffler E, Crimi C, Crimi N.

Acta Paediatr. 2017 Oct;106(10):1706. doi: 10.1111/apa.13979. Epub 2017 Jul 26. No abstract available.

PMID:
28695646
12.

Point-of-care blood eosinophil count in a severe asthma clinic setting.

Heffler E, Terranova G, Chessari C, Frazzetto V, Crimi C, Fichera S, Picardi G, Nicolosi G, Porto M, Intravaia R, Crimi N.

Ann Allergy Asthma Immunol. 2017 Jul;119(1):16-20. doi: 10.1016/j.anai.2017.05.016.

PMID:
28668237
13.

Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?

Johannson KA, Strâmbu I, Ravaglia C, Grutters JC, Valenzuela C, Mogulkoc N, Luppi F, Richeldi L, Wells AU, Vancheri C, Kreuter M; Erice ILD Working Group.

Lancet Respir Med. 2017 Jul;5(7):591-598. doi: 10.1016/S2213-2600(17)30219-9. Review.

PMID:
28664861
14.

Integrated approach of nutritional and molecular epidemiology, mineralogical and chemical pollutant characterisation: the protocol of a cross-sectional study in women.

Barchitta M, Quattrocchi A, Maugeri A, Barone G, Mazzoleni P, Catalfo A, De Guidi G, Iemmolo M, Crimi N, Agodi A.

BMJ Open. 2017 Apr 4;7(4):e014756. doi: 10.1136/bmjopen-2016-014756.

15.

Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab.

Heffler E, Fichera S, Nicolosi G, Crimi N.

J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):852-854. doi: 10.1016/j.jaip.2017.01.003. Epub 2017 Mar 1. No abstract available.

PMID:
28258855
16.

Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux.

Heffler E, Crimi C, Brussino L, Nicola S, Sichili S, Dughera L, Rolla G, Crimi N.

J Breath Res. 2016 Dec 22;11(1):016002. doi: 10.1088/1752-7163/11/1/016002.

PMID:
28004646
17.

Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics.

Scichilone N, Crimi C, Benfante A, Battaglia S, Iemmolo M, Spatafora M, Crimi N.

Asthma Res Pract. 2016 Jan 4;2:1. doi: 10.1186/s40733-015-0019-x. eCollection 2016.

18.

Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice.

Bongiorno MR, Crimi N, Corrao S, Allotta A, Arena A, Brusca I, Heffler E, Malara G, Milioto M, Pistone G, Porto M, Raia E, Valenti G.

Ann Allergy Asthma Immunol. 2016 Dec;117(6):703-707. doi: 10.1016/j.anai.2016.08.006. Epub 2016 Oct 6. Review. No abstract available.

PMID:
27720581
19.

The Arg/Arg polymorphism of the ADRB2 is associated with the severity of allergic asthma.

Scichilone N, Caponetto C, Fagone E, Benfante A, Paternò A, Heffler E, Crimi N, Vancheri C.

J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1251-1252. doi: 10.1016/j.jaip.2016.06.014. Epub 2016 Jul 13. No abstract available.

PMID:
27421901
20.

Asthma control and bronchodilator response.

Heffler E, Crimi N.

Respir Med. 2016 Jul;116:109. doi: 10.1016/j.rmed.2016.05.013. Epub 2016 May 15. No abstract available.

Supplemental Content

Loading ...
Support Center